Thermo Fisher Scientific Publishes New Edition of ‘Insights’ Newsletter
News Oct 05, 2009
Thermo Fisher Scientific Inc., has just published the latest edition of Insights, a quarterly newsletter focusing on the leading-edge genomic technologies available from Thermo Scientific Genomics. Insights provides life scientists with a mix of product application notes, user stories, latest product information and answers to frequently asked questions to assist them in their research.
Featured articles in the latest edition (Issue 23) include:
• Genome-scale RNAi screens at your benchtop - Decode RNAi Viral Screening Libraries
• Progressive solutions for advancing drug discovery and therapeutic development - RNAi Discovery and Therapeutic Services
• Optimized Quantitation of Marek's Disease Virus using Multiplex QPCR - ABsolute Blue & ABsolute Fast QPCR master mixes
• Successful siRNA Delivery into Primary Neuronal Cells - Accell siRNA reagents
• Robust Silencing Paired with Sensitive Detection as Part of an Optimized Gene Silencing System - ABsolute Blue & ABsolute Fast QPCR master mixes
To download a copy electronically or sign up to receive the newsletter as hard copy, please visit http://www.dharmacon.com/m360/ or talk to your local Thermo Scientific Genomics representative.
Thermo Scientific is part of Thermo Fisher Scientific Inc., the world leader in serving science.
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE